CA
NZ
UK
AU
IND
US
Natera, Inc. Chief Financial Officer Brophy Michael Burkes filed a Form 4 on October 29, 2026, reporting the sale of common stock on October 27 and October 28, 2026, both transactions made pursuant to Rule 10b5-1(c) written plans to cover tax withholding obligations tied …
Steven Leonard Chapman, CEO and President of Natera, Inc., filed a Form 4 on October 29, 2026, disclosing two open-market disposals of common stock on October 27 and October 28, 2026, both executed under Rule 10b5-1(c) plans to satisfy tax withholding obligations tied to …
John Fesko, President and Chief Business Officer of Natera, Inc., filed a Form 4 on October 29, 2026, disclosing two open-market sales of common stock on October 27 and October 28, 2026, executed to satisfy tax withholding obligations tied to vesting restricted stock units.
Daniel Rabinowitz, Secretary and Chief Legal Officer of Natera, Inc., filed a Form 4 on October 29, 2026, disclosing two sales of common stock on October 27 and October 28, 2026, both executed under Rule 10b5-1 plans to satisfy tax withholding obligations tied to …
Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc. (NASDAQ:NTRA), filed a Form 4 on October 29, 2026, disclosing two sales of common stock on October 27 and October 28, 2026, executed under Rule 10b5-1 plans to cover tax withholding obligations related to vesting …
Matthew Rabinowitz, Executive Chairman and Director of Natera, Inc., filed a Form 4 on October 29, 2026, disclosing the sale of 1,718 shares of common stock on October 27, 2026, to satisfy tax withholding obligations connected to vesting Restricted Stock Units.
Director and co-founder Sheena Jonathan filed a Form 4 with the SEC on October 29, 2026, reporting two sales of Natera, Inc. common stock on October 27 and October 28, 2026, executed to satisfy tax withholding obligations tied to vesting RSUs.
Frank Anthony Balow III filed an initial statement of beneficial ownership with the SEC on October 29, 2026, disclosing his securities holdings upon becoming Chief Financial Officer of Monolithic Power Systems, Inc. (NASDAQ:MPWR), with an event date of October 27, 2026.
Lisa Johnson-Pratt, Chief Commercial Officer of Aspen Neuroscience, Inc. (NASDAQ:ASPE), filed an initial statement of beneficial ownership on October 29, 2026, disclosing three stock option grants covering a total of 146,729 shares of common stock.
Cynthia Dorothy Perettie filed an initial statement of beneficial ownership with the SEC on October 29, 2026, disclosing her status as a newly reporting director of Aspen Neuroscience, Inc. (NASDAQ:ASPE).
Please wait processing your request...